Heart Occlusion Device Self-Centering Waist and ePTFE Coverings

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current heart occlusion devices for congenital cardiac defects, such as PFO, are complex to implant, have high complication rates due to thrombus formation, tissue injury, and require multiple sizes, making them inefficient and costly for clinical use.

Innovation Solution

A heart occlusion device with a self-centering mechanism using two flexible wires with shape memory properties, forming discs separated by a waist that conforms to the defect size and shape, providing a custom fit and reducing thrombogenicity through ePTFE coverings, allowing for repositionability and fewer required sizes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional heart occlusion devices are used, then the defect can be closed, but the device complexity and number of required sizes increase

Engineering Contradiction:
Improvedefect closure effectivenessVSAvoiddevice structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies universality by designing a single device architecture that can accommodate multiple defect sizes through adjustable waist compression. The device functions universally across different PFO sizes by modifying the compression force applied to the waist, eliminating the need for multiple specialized device sizes while maintaining effective closure.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent implements dynamics through the adjustable waist compression mechanism. The waist can be dynamically compressed to different degrees to match various defect sizes, transforming a static device into a dynamic one that adapts to different anatomical configurations, thereby reducing device complexity.

Inventive Principle:
Principle #15Dynamics

2Reliability

If traditional heart occlusion devices are used, then the defect can be closed, but the risk of thrombus formation and tissue injury increases

Engineering Contradiction:
Improvedefect closure effectivenessVSAvoidthrombus formation and tissue injury
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies flexible shells and thin films by using an ePTFE covering that conforms to the defect geometry. This flexible membrane provides a smooth, non-thrombogenic surface that reduces blood clot formation while maintaining the structural integrity needed for effective defect closure.

Inventive Principle:
Principle #30Flexible shells and thin films

Solution Approach 2:

The patent implements parameter changes by modifying the physical and chemical properties of the device surface through ePTFE coating. This material change reduces thrombogenicity and improves biocompatibility, directly addressing the harmful effects of thrombus formation and tissue injury while maintaining closure effectiveness.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If multiple device sizes are used, then different defect sizes can be accommodated, but the manufacturing cost and clinical efficiency decrease

Engineering Contradiction:
Improvedefect size accommodationVSAvoidclinical efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent applies universality by creating a single device platform that serves multiple defect size requirements. The adjustable waist compression mechanism allows one device design to fit various PFO sizes, eliminating the need to manufacture and stock multiple specialized sizes, thereby improving clinical efficiency and productivity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent implements parameter changes by varying the compression force applied to the waist rather than changing the entire device structure. This parameter adjustment allows a single device to adapt to different defect sizes, reducing manufacturing complexity and improving clinical workflow efficiency.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If devices with high septal profile are used, then the defect can be occluded, but the body adaptation and patient comfort worsen

Engineering Contradiction:
Improvedefect occlusionVSAvoiddevice profile and conformability
Core Design Contradiction:
ReliabilityVSShape

Solution Approach 1:

The patent applies flexible shells and thin films through the ePTFE covering that drapes over the waist and discs. This flexible membrane allows the device to conform to the irregular geometry of the PFO defect, creating a low-profile configuration that improves body adaptation and patient comfort while maintaining reliable occlusion.

Inventive Principle:
Principle #30Flexible shells and thin films

Solution Approach 2:

The patent implements curvature by designing the waist and discs with smooth, rounded contours that follow the natural curvature of the interatrial septum. This curved geometry eliminates sharp edges and high profiles, improving device conformability and patient comfort while ensuring effective defect occlusion.

Inventive Principle:
Principle #14Spheroidality (Curvature)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device achieves a secure, conformable, and efficient closure of cardiac defects with reduced complications, improved anatomical conformability, and fewer sizes needed, enhancing patient safety and clinical efficiency.

Implementation Method 1

each of the first and second wires is comprised of a shape memory capability such that the wires can be collapsed and distorted in a catheter during delivery but resume and maintain their intended shape

Methodology Applied
Scientific EffectShape memory: Shape Memory Alloy

Data Source

PatentEP2744412B1Heart occlusion devices
Publication Date: 2019.10.23 WL GORE & ASSOC INC
  • EP2744412B1 patent drawingFigure 1
  • EP2744412B1 patent drawingFigure 2~3
  • EP2744412B1 patent drawingFigure 4~5

AI summary

The disclosure is directed to a heart occlusion device and a method for occluding an aperture defect in a heart. The heart occlusion device includes two separate wires 12, 14. Each wire forms geometric shapes that together form a distal plate and a proximal plate. The first plate is disposed in a first plane. The second plate is disposed in a second plane that is parallel to and remote from the first plane. The distal plate and the proximal plate are separated by a self-centering waist. The proximal plate is attached to a hub. A similar hub is optional on the distal plate. The plates further include coverings which form a sealant to occlude an aperture in a tissue. The wires forming the plates have a shape-memory capability such that they can be collapsed and distorted in a catheter during delivery but resume and maintain their intended shape after delivery.